Mimi Guebre‐Xabier
- Immunology top 10%
- Epidemiology top 10%
- Infectious Diseases top 5%
- Molecular Biology
- Public Health, Environmental and Occupational Health top 10%
- Co-authors
- Robert SchwenkGregory M. GlennLarry EllingsworthUrszula KrzychScott A. HammondAnna Mae DiehlShiqi YangJianmei Yu
- Topics
- Immunotherapy and Immune Responses (6 papers)Respiratory viral infections research (5 papers)Immune Cell Function and Interaction (5 papers)
- Partner nations
- United StatesEthiopiaUnited Kingdom
In The Last Decade
Mimi Guebre‐Xabier
22 papers receiving 806 citations
Peers
Comparison fields: 5 of 72
- Immunology 335
- Epidemiology 279
- Infectious Diseases 277
- Molecular Biology 182
- Public Health, Environmental and Occupational Health 150
Countries citing papers authored by Mimi Guebre‐Xabier
This map shows the geographic impact of Mimi Guebre‐Xabier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mimi Guebre‐Xabier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mimi Guebre‐Xabier more than expected).
Fields of papers citing papers by Mimi Guebre‐Xabier
This network shows the impact of papers produced by Mimi Guebre‐Xabier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mimi Guebre‐Xabier. The network helps show where Mimi Guebre‐Xabier may publish in the future.
Co-authorship network of co-authors of Mimi Guebre‐Xabier
This figure shows the co-authorship network connecting the top 25 collaborators of Mimi Guebre‐Xabier. A scholar is included among the top collaborators of Mimi Guebre‐Xabier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mimi Guebre‐Xabier. Mimi Guebre‐Xabier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 4 | |
| 4 | 36 | |
| 5 | 149 | |
| 6 | 28 | |
| 7 | 9 | |
| 8 | 15 | |
| 9 | 20 | |
| 10 | 21 | |
| 11 | 37 | |
| 12 | 57 | |
| 13 | 92 | |
| 14 | 48 | |
| 15 | 163 | |
| 16 | 5 | |
| 17 | 48 | |
| 18 | 1 | |
| 19 | 1 | |
| 20 | Sero-epidemiological survey of Toxoplasma gondii infection in Ethiopia. | 19 |
About Mimi Guebre‐Xabier
Mimi Guebre‐Xabier is a scholar working on Infectious Diseases, Immunology and Virology, having authored 24 papers that have together received 858 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (6 papers), Respiratory viral infections research (5 papers) and Immune Cell Function and Interaction (5 papers). The work is most often cited by research in Immunology (335 citations), Infectious Diseases (277 citations) and Virology (42 citations). Mimi Guebre‐Xabier has collaborated with scholars based in United States, Ethiopia and United Kingdom. Frequent co-authors include Robert Schwenk, Gregory M. Glenn, Larry Ellingsworth, Urszula Krzych, Scott A. Hammond, Anna Mae Diehl, Shiqi Yang, Jianmei Yu, Gale Smith and Nita Patel. Their work appears in journals such as Nature Communications, The Journal of Immunology and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.